Corporate Giving

Medical Education Grant Requests

Ipsen Biopharmaceuticals, Inc. seeks to advance scientific knowledge and enhance patient care by funding certain types of requests for healthcare provider or patient education from the medical and scientific community. Our areas of therapeutic interest fall into 3 categories: oncology, neurosciences, and rare diseases. In particular, we are interested in funding education relating to acromegaly, neuroendocrine tumors, pancreatic cancer, and neuromuscular and movement disorders. In general, Ipsen has a preference for programs that are supported by multiple organizations.

Who May Request a Grant?

Grant requests may come from academic institutions, state or national medical associations or societies, disease foundations and associations, patient associations, or other educational providers. For academic institutions, the University Grants Office should apply for the grant, rather than an individual department or research group. Grants will not be given to individuals. Ipsen Biopharmaceuticals, Inc., does not fund noneducational expenses.

What Types of Grants Do We Fund?

Healthcare professional educational grants

Educational grants will be considered with a preference for accredited continuing education (CE) programs. The primary audience for these grants should be healthcare professionals or patients. Ipsen Biopharmaceuticals, Inc., funds educational seminars, webinars, and symposia; the development of educational materials; and other types of educational programs with demonstrated educational value. Only requests with strong needs assessments and the ability to measure educational outcomes will be funded. For consideration, grant applications must be submitted with all required documentation at least 90 days prior to the scheduled event. Grant requests will be reviewed by Ipsen Biopharmaceuticals, Inc.'s Grant Committee. Grants are reviewed on the basis of scientific, medical, and/or public health criteria.

Each educational grant will be considered using the following guidelines and standards, as applicable:

  • Office of Inspector General (OIG) guidelines
  • Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support
  • Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals
  • American Medical Association (AMA) Ethical Guidelines for Gifts to Physicians from Industry
  • Ipsen Biopharmaceuticals, Inc., policies and procedures
  • Other relevant guidelines and regulations

Grant approvals are not connected to or conditioned upon the purchasing, prescribing, providing favorable recommendations for, or otherwise supporting Ipsen Biopharmaceuticals, Inc. products. The funding of a grant request does not impose an obligation, expressed or implied, on the recipient to purchase, prescribe, provide favorable formulary status for, or otherwise support Ipsen Biopharmaceuticals, Inc. products. Formal notifications of grant awards will be made in writing to the applicant organization and supersede any prior oral or written understandings or communications between the applicant and Ipsen Biopharmaceuticals, Inc.

Endocrinology

The Endocrinology Group is interested in funding education relating to the epidemiology, diagnosis, and/or treatment of the following area:

  • Pituitary disease, including acromegaly
  • Hormonal dysfunction, including severe primary IGF-1 deficiency (SPIGFD)

Neurology

The Neurology Group is interested in funding education relating to epidemiology, diagnosis, and/or treatment in the following areas:

  • Cervical dystonia and other dystonic disorders
  • Spasticity
  • Other movement disorders

Oncology

The Oncology Group is interested in funding education relating to epidemiology, diagnosis, and/or treatment in the following areas:

  • Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
  • Carcinoid syndrome
  • Pancreatic cancer

What Do You Need to Submit a Grant?

Before consideration, a grant application must contain all of the following documents:

  • Letter of Request - including a robust needs assessment that demonstrates an educational need for the program and a brief description of who is requesting the grant, what is being requested, the date, and the location of the activity
  • Agenda or brochure - including a detailed description of the event or a synopsis of materials to be created
  • Budget - a detailed budget for the total event/project, including: (a) the total amount of funds requested from Ipsen Biopharmaceuticals, Inc.; (b) a breakdown of expenses and projected number of attendees; (c) the percentage of funding requested from Ipsen Biopharmaceuticals, Inc., to the total funding for the activity; and (d) the number of sponsors that are being approached to support the event. Preference will be given to those events funded by more than one sponsor
  • W9 - tax form with tax ID number for the entity receiving the check. If an entity is tax exempt, you may submit a Letter of Exemption instead. Click here to download a W9 form
  • Letter of Agreement (LOA) - the Ipsen Biopharmaceuticals, Inc., US Letter of Agreement is required for funding all grant requests. Please click here for the LOA Template. Please complete the form, sign, scan, and upload
  • CE Certificate - CE certificate for the provider. This requirement is waived for non-CE educational activities

Charitable Contributions

In addition, Ipsen Biopharmaceuticals, Inc. considers funding requests from patient care organizations and groups that intend to provide education and raise awareness within the oncology, endocrine, and neurology therapeutic areas through educations seminars, materials, sponsorships, or other mechanisms.

Ipsen is committed to supporting organizations that share our goals to empower patients and enhance patient care. Through charitable contributions and sponsorships, we dedicate our resources to support the education of patients, families, and caregivers, as well as the healthcare community.

Ipsen Biopharmaceuticals, Inc., may provide funding to qualified 501(c)(3) organizations, including patient advocacy groups and professional medical associations in the United States, supporting each organization's broad charitable purpose or mission. Charitable contributions could take the form of money, goods (including in-kind Ipsen product donations), or services but are distinguished from medical education grants.

Ipsen Biopharmaceutical, Inc.’s areas of therapeutic interest fall into 3 categories: oncology, neurosciences, and rare diseasess. In particular, Ipsen Biopharmaceuticals, Inc. is interested in organizations related in acromegaly, Severe Primary IGFD, Gastroenteropancreatic neuroendocrine tumors (GEP-NETs), carcinoid syndrome, pancreatic cancer, and neuromuscular and movement disorders.

What Types of Contributions Do We Fund?

Charitable contributions

Ipsen may fund healthcare charitable contributions related to the following: disease-state focused patient or community education or advocacy; health screening and surveying; improved patient access to care (eg, transportation costs); and/or organizations whose general mission is to benefit specific patient groups. If the target audience of a patient/community education program also includes HCPs, the request may not be supported as a charitable contribution.

Non-healthcare charitable contributions

Ipsen may donate money, goods, or services to organizations or programs that exist for broad public benefit not related to products or healthcare topics.

Policy-focused healthcare charitable contributions

Ipsen may contribute to third-party, not-for-profit organizations where the funds are to be used for the organization's specific mission-related activities that align with Ipsen's public policy goals. This includes, but is not limited to, patient education on public policy issues, policy-related access to healthcare issues, and support of charities whose general mission is to further healthcare policy (and does not include healthcare professionals' CME/CE or disease state, medical, or clinically focused activities).

Special events

Ipsen may contribute to third-party, not-for-profit organizations whose goals align with Ipsen's public policy goals, to help fund their fundraising dinners, walks, biking and golf events, galas, awards ceremonies, and other similar events. Special events are activities that do not present tangible benefits to Ipsen.

Before consideration, a charitable contribution application must contain all of the following documents:

  • Letter of Request - must include:

    • A brief description of your organization
    • A statement describing the requester’s charitable mission and why it is important
    • The relationship, if any, of the requester to Ipsen
    • The date(s) of the program or event (if applicable)
    • The total budget and the donation amount and percentage being requested from Ipsen
    • The projected number of attendees (if applicable)
    • The program location, including the venue, city, and state (if applicable)
    • The payee and address
    • In the case of requests for product (in-kind support), the requested quantity of drug and the way the drug will be used in the program
    • Agenda or brochure—including a detailed description of the program or a synopsis of materials to be created (if applicable)
    • Evidence of the existence of the requester and 501(c)(3) status, such as a tax identity number
    • A description of any prior donations made by Ipsen to the requestor and how they were used
    • The number of sponsors, other than Ipsen, that are being approached to support the request
  • W9 - tax form with tax ID number for the entity receiving the check. If an entity is tax exempt, you may submit a Letter of Exemption instead. Click here to download a W9 form.

  • Letter of Agreement (LOA) - A Letter of Agreement is required for funding all charitable contribution requests. Please provide your own Letter of Agreement for Ipsen review.

Evaluation

All of the documents must be completed and submitted at least 90 days prior to the event to allow enough time for proper review and for the charitable contribution funding to be received by the grant requestor before the program occurs.